Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience

47Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Telogen effluvium (TE) is one of the most common form of hair loss in women. Many triggers have been identified, as stress, drugs, trauma, endocrine disease, nutritional deficiencies, and febrile states. We report three cases of TE occurred after severe Sars-Cov-2 infection and provide our clinical management, according to Sars-Cov-2 hygiene measures. Only one case report has been found in the literature associating anagen effluvium during severe Sars-Cov-2 infection. Other studies reported the exacerbation of a preexisting TE, correlated to the stress of lockdown. In our cases, patients never had a TE diagnosis before and did not report previous evident hair loss. TE can be associated with post severe Sars-Cov-2 infection. From our revision of the literature, this is the first case-series describing TE in post severe Sars-Cov-2 patients. Further studies are needed to evaluate the relationship between TE and Sars-Cov-2 infection.

Cite

CITATION STYLE

APA

Rizzetto, G., Diotallevi, F., Campanati, A., Radi, G., Bianchelli, T., Molinelli, E., … Offidani, A. (2021). Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatologic Therapy, 34(1). https://doi.org/10.1111/dth.14547

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free